🕒 Tuesday 9 June 2026 Tue, 9 June 2026

Zenith Minerals urges shareholders to accept Forrestania Resources’ takeover offer valuing Zenith at a 78.6% premium to its 30-day VWAP, promising access to near-term production and a stronger combined gold portfolio.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.

Saferoads Holdings (ASX: SRH) has acquired Chameleon AMLS, adding a new modular trailer product line and appointing its founder Andrew Kaye to the board.

Tasman Resources has completed the first tranche of a $4 million share placement to fund a larger drilling program at its Parkinson Dam Project in South Australia.

Larvotto Resources has secured a binding seven-year gold concentrate offtake agreement with global giant Glencore for its Hillgrove project, complementing an existing antimony deal and paving the way for production in August 2026.

Diatreme Resources has finalised the sale of its Cape Flattery Silica Project to a joint venture with Sibelco, receiving $2.1 million in reimbursements and positioning for up to $7.4 million in total funding.

The Supreme Court of Western Australia has approved Genesis Minerals’ acquisition of Magnetic Resources, setting a clear timetable for scheme implementation and ASX trading suspension.

Novo Resources has delivered a maiden inferred resource estimate for the Leven Star Reef within its Belltopper Gold Project, outlining 87,000 ounces of contained gold and setting the stage for further exploration and resource expansion.

Macquarie Group Limited has fixed the Dividend Reinvestment Plan (DRP) price at AUD 233.12 per share for its final dividend payable on 2 July 2026, applying a 1.5% discount to the 10-day volume weighted average price. The final dividend is AUD 4.20 per share, fully franked at 35%.

Alice Queen Limited has pushed back the closing date for its partially underwritten rights issue to 19 June 2026, giving shareholders more time to subscribe at 0.9 cents per share.

Imugene’s off-the-shelf CAR T therapy azer-cel has won FDA Fast Track Designation for relapsed or refractory CLL/SLL and MZL, backed by compelling Phase 1b response rates.

Spenda Limited (ASX:SPX) has kicked off an $8.545 million accelerated entitlement offer at a steep discount, aiming to strengthen its balance sheet, reduce debt, and support its strategic reset towards profitability.

oOh!media is actively engaging with several financial sponsors, including Bain Capital, Pacific Equity Partners, and I Squared Capital, over potential change of control deals, having received conditional non-binding indicative offers.

Cadoux Limited has inked a joint venture to earn up to 80% of the Wimmera Mineral Sands Project in Victoria, revealing promising high-grade drilling results at its Danube prospect. The project aims to feed Cadoux’s Minhub processing hub, targeting critical heavy rare earths supply.

Whitefield Income Limited has successfully completed its pro-rata entitlement offer and shortfall offer, raising the maximum A$108 million at A$1.22 per share with demand exceeding supply.

DXN Limited has secured A$7 million from institutional investors to fund delivery of its maiden AI HPC modular data centre contract and expand manufacturing capacity in Southeast Asia.

Sunshine Metals has agreed to sell its Hodgkinson Project to EQ Resources for $250,000, freeing up capital and management bandwidth to accelerate gold production at Mt Moss and exploration at Sybil.

Hammer Metals (ASX:HMX) has voluntarily suspended trading of its shares pending an announcement about a potential material corporate transaction that could change control of the company.

OncoSil Medical has cleared a major regulatory hurdle as its Humanitarian Device Exemption application nears FDA approval, while its TRIPP-FFX trial shows promising results combining OncoSil with standard chemotherapy for pancreatic cancer.

Greenvale Energy has completed initial product assessments for its Alpha Project bitumen samples, successfully separating volatile fractions and producing a bitumen-like material. The company plans further processing to meet industry specifications and awaits independent certification.

Strata Minerals has validated a significant gold mineralised system along a 9.5km corridor at its Zelica South Project in Western Australia, with rock chip samples hitting up to 11.78 g/t Au and silver anomalies supporting a fertile hydrothermal system.

ACDC Metals has reported promising surface assays from its Mount Jackson project in Nevada, with gold grades up to 2.35 g/t and copper reaching 14.9% at key zones. The company is advancing towards a maiden drilling program in Q4 2026 backed by ongoing capital raising.

Resonance Health is progressing its MRI Liver Fibrosis device through late-stage clinical validation, targeting FDA biomarker qualification, while maintaining a profitable SaaMD platform and forecasting $16 million revenue for FY26.

Elanor Investors Group has finalised a $125 million recapitalisation that slashes its cost of capital and reduces debt, setting the stage for a leaner, capital-light funds management model and imminent ASX reinstatement.